Nidek claims Canadian patent victory sets US precedent
This article was originally published in Clinica
Nidek claims that the decision announced last week to uphold an earlier patent lawsuit in Canada in its favour against Visx opens the way to victory in similar litigation in the US. For its part, Visx dismisses the decision as a "non-event for both parties", and accuses the Japanese company of making "misleading and inaccurate" comments in its press release.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.